Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase in silico approach
{{output}}
Background: The COVID-19 pandemic has created an urgent need for effective therapeutic agents. The SARS-CoV-2 Main Protease (Mpro) plays a crucial role in viral replication and immune evasion, making it a key target for drug deve... ...
